Making clinical decisions in the management of myelofibrosis (MF) can be challenging owing to the heterogeneity of the disease, patient population and their often burdensome clinical manifestations. The goal of this learning activity is to provide doctors with a concise review of the management of MF.
Upon completing this module, participants will have a better understanding of the following aspects:
- Current treatment guidelines
- Role of available pharmacotherapy and nonpharmacotherapy
- Switching between treatments
- Challenges in treatment
Dr Haifa Kathrin Al-Ali, MD, PD
Department of Haematology and Medical Oncology
University Hospital of Halle (Saale)
• Q&A session
Who should participate:
Please watch the video before attempting the assessment questions.
Terms & Conditions:
■ Participants must obtain a minimum score of 8/10 (80%) to be awarded 1 point.
■ MIMS Education and MIMS Medica shall not be responsible or liable for the outcome of your CPD points
To play this video, you are required to have a media player such as Windows Media Player (PC), QuickTime (MAC) or another third party media player.